Navigation Links
BioMarin Announces Fourth Quarter and Full Year 2008 Financial Results
Date:2/18/2009

Operating expenses: Cost of sales (excludes amortization) 5,224 11,665 18,359 52,509 Research and development 24,015 25,733 78,600 93,291 Selling, general and administrative 23,891 28,730 77,539 106,566 Amortization of intangible assets 1,093 1,093 4,371 4,371 Total operating expenses 54,223 67,221 178,869 256,737 Income (loss) from operations (9,369) 32,056 (57,288) 39,756 Equity in the income (loss) of BioMarin/Genzyme LLC 9,366 (579) 30,525 (2,270) Interest income 7,383 3,231 25,932 16,388 Interest expense (4,080) (4,096) (14,243) (16,394) Impairment loss on investment -- (4,056) -- (4,056) Income (loss) before income taxes 3,300 26,556 (15,074) 33,424 Income Taxes 729 2,050 729 2,593 Net income (loss) $2,571 $24,506 $(15,803) $30,831 Net income (loss) per share, basic $0.03 $0.25 $(0.16) $0.31 Net income (loss) per share, diluted $0.03 $0.21 $(0.16) $0.29 Weighted average common shares outstanding, basic 96,931 99,777 95,878 98,975 Weighted average common shares outstanding, diluted 101,193 128,296 95,878 103,572

The following is the stock-based compensation expense included in the respective captions of the consolidated statements of operations above:

                                           Three Months
                                              Ended         Twelve Months
                                           December 31,  
'/>"/>
SOURCE BioMarin Pharmaceutical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. BioMarin to Host Fourth Quarter and Full Year 2008 Financial Results Conference Call and Webcast on Wednesday, February 18 at 5:00 p.m. ET (23:00 CET)
2. BioMarin to Present at the Piper Jaffray Healthcare Conference
3. BioMarin Announces the Planned Retirement of Dr. Emil Kakkis, Chief Medical Officer
4. BioMarin to Present at the Credit Suisse Healthcare Conference
5. BioMarin Announces Third Quarter 2008 Financial Results
6. BioMarin Corrects Information Included in Bloomberg Article
7. BioMarin to Present at the Merrill Lynch Global Pharmaceutical Conference
8. BioMarin to Present at the Morgan Stanley Global Healthcare Conference
9. BioMarin to Present at the Citi Biotech Day
10. BioMarin Announces Roll-Out of National PKU Registry
11. BioMarin to Host Second Quarter 2008 Financial Results Conference Call and Webcast on Tuesday, August 5 at 5:00 p.m. ET (23:00 CET)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... -- US-Australian drug discovery company, Novogen Limited (ASX: NRT; ... scientific review has identified high value opportunities for ... patient need. Novogen is moving as quickly as ... entering into Phase 1 clinical trials with our ... Officer, Iain Ross , said that following ...
(Date:8/31/2015)... 31, 2015 FLX Bio, Inc., a biopharmaceutical ... cancer immunotherapies, announced today that it has appointed ... and William Ho , M.D., Ph.D., as Chief ... management team led by veterans of Flexus Biosciences, Inc., ... Scientific Officer; Jay Powers , Ph.D., Vice President, ...
(Date:8/31/2015)... 31, 2015 Trimb Healthcare AB ("Trimb") today ... YouMedical Group BV ("YouMedical"), a Dutch OTC company with ... sales of approximately EUR 16 million, with solid growth ... "Our ambition is to build a leading international OTC ... that goal. YouMedical gives us a stronger North European ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... the world's most successful food and beverage processors, equipment manufacturers and leaders in ... product inspection and industrial weighing and formulation for manufacturers of bakery and snacks; ...
Breaking Biology Technology:Novogen Announces The Outcome Of A Comprehensive Science Review 2Novogen Announces The Outcome Of A Comprehensive Science Review 3Novogen Announces The Outcome Of A Comprehensive Science Review 4Novogen Announces The Outcome Of A Comprehensive Science Review 5Novogen Announces The Outcome Of A Comprehensive Science Review 6FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925 2FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925 3FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925 4METTLER TOLEDO Hosts Food Safety Educational Center at 2015 PROCESS EXPO 2
... REYKJAVIK, Iceland, April 3, 2008 U.S.,Preventive Medicine(R), ... Genetics, the global leader in gene discovery, today,announced ... add genetic testing to,expand both companies, personalized medicine ... of the letter of intent with deCODE is ...
... Research Results To Be Presented at Experimental Biology ... Wellmune WGP(R), a natural,immune-enhancing ingredient from Biothera, ... for study subjects to miss work or school ... the 2008 Experimental,Biology annual meeting., Don Cox, ...
... ,Pharmacyclics, Inc. (Nasdaq: PCYC ) today announced ... drug candidates at the,American Association for Cancer Research ... at the San Diego Convention Center in San ... histone deacetylase(HDAC),inhibitor, which is now in a multicenter ...
Cached Biology Technology:U.S. Preventive Medicine and deCODE Genetics Sign Letter of Intent to Expand Personalized Medicine Platform 2U.S. Preventive Medicine and deCODE Genetics Sign Letter of Intent to Expand Personalized Medicine Platform 3Wellmune WGP(R) Supplementation Alleviates Duration, Severity and 'Down Time' Due to Cold Symptoms 2Wellmune WGP(R) Supplementation Alleviates Duration, Severity and 'Down Time' Due to Cold Symptoms 3Pharmacyclics Announces Multiple Presentations at the American Association for Cancer Research Annual Meeting 2Pharmacyclics Announces Multiple Presentations at the American Association for Cancer Research Annual Meeting 3Pharmacyclics Announces Multiple Presentations at the American Association for Cancer Research Annual Meeting 4
(Date:8/31/2015)... -- Growing need for data security coupled ... to drive India biometrics market   ... " India Biometrics Market Forecast & Opportunities, 2020 ", biometrics ... grow at a CAGR of over 35% during 2015 - ... extensive use of biometric technology in the government sector. Ongoing ...
(Date:8/24/2015)... , August 24, 2015 The ... ,s largest biometrics manufacturer DERMALOG and its customized solutions ... "2015 African Biometrics Company of the Year Award". DERMALOG is ... Nigeria .   -Cross reference: Picture is ... - On Thursday evening, in ...
(Date:8/19/2015)... Aug. 19, 2015  VOXX International Corporation (Nasdaq: ... entered into a Definitive Agreement to purchase the ... authentication market leader EyeLock through an acquiring entity.  ... a controlling interest in the acquiring entity. The ... of due diligence.  Expanding on its existing supply ...
Breaking Biology News(10 mins):India Biometrics Market to Grow at Over 35% Through 2020, Says TechSci Research 2India Biometrics Market to Grow at Over 35% Through 2020, Says TechSci Research 3Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 2Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5
... researchers at Oregon State University, the world,s multi-billion dollar foundry ... that produces metal castings used in everything from water pumps ... thousands of years to before Greek and Roman times. It ... continues to evolve. Some modern technologies use various types ...
... Calif -- Nitrogen is a beneficial plant fertilizer in ... ecosystems, such as water pollution, acidification of soils, increased ... a decline of native plant diversity. Over the ... amount of plant-available nitrogen inputs from the atmosphere compared ...
... for Experimental Biology (FASEB) commends Air India for continuing ... company, FASEB expressed its appreciation for Air India,s perseverance ... groups to discontinue shipping laboratory animals. "Animals are crucial ... the world are dependent upon their safe and humane ...
Cached Biology News:Sweet new approach discovered to help produce metal casting parts, reduce toxicity 2Researchers to study impacts of pollutant nitrogen on plant species diversity 2
PlusOne EDTA, disodium salt, 100 g. Category: Electrophoresis Systems & Standards & Reagents, Electrophoresis Standards and Reagents, Buffers....
...
Normal human serum collected off the clot from healthy normal humans. Each donor unit is negative for anti-HIV 1&2, HIV-Ag, HCV, and HBsAg by FDA required tests...
Normal human AB serum, pooled...
Biology Products: